GRI Bio, Inc. (GRI) Financials

GRI Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 11.4 million 1.1 million
March 31, 2026 11.3 million 794000
Dec. 31, 2025 8.7 million 2.7 million
Sept. 30, 2025 4.8 million 2.8 million

GRI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -1.4 million 33000
March 31, 2026 -3.7 million 31000
Dec. 31, 2025 -3.0 million 67000
Sept. 30, 2025 -2.3 million 465000

GRI Net Income

No data available :(

GRI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 10.9 million - -
March 31, 2026 11.0 million - 58000
Dec. 31, 2025 8.2 million - 71000
Sept. 30, 2025 4.1 million - 84000

GRI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 1.8 million
March 31, 2026 1.2 million
Dec. 31, 2025 497696
Sept. 30, 2025 93625

GRI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 407000 1.2 million -
March 31, 2026 - 361000 1.6 million -
Dec. 31, 2025 3000 1.6 million 1.0 million -
Sept. 30, 2025 - 1.8 million 1.6 million -

GRI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 1000
March 31, 2026 - 1000
Dec. 31, 2025 - 1000
Sept. 30, 2025 6.3 million 1000

GRI

Price: $1.71

52 week price:
1.36
80.36

Earnings Per Share: 38.89 USD

P/E Ratio: 0.04

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 2375

Market Capitalization: 3.0 million

Links: